RecruitingPhase 3NCT06922240

Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART)

Studying Chronic thromboembolic pulmonary hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Suqiao Yang
Intervention
Riociguat(drug)
Enrollment
68 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (3)

Collaborators

China-Japan Friendship Hospital · Beijing Anzhen Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06922240 on ClinicalTrials.gov

Other trials for Chronic thromboembolic pulmonary hypertension

Additional recruiting or active studies for the same condition.

See all trials for Chronic thromboembolic pulmonary hypertension

← Back to all trials